Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Biomedicines
|
April 23, 2022
Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients
Ping-Hsun Wu, Rie Io Glerup, My Hanna Sofia Svensson, et al.
Clinical Transplantation
|
August 16, 2014
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Dag Olav Dahle, Trond Jenssen, Hallvard Holdaas, et al.
Clinical Kidney Journal
|
July 2, 2025
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients
Maria Tydén, Magnus E Westerlund, Kevin Duarte, et al.
Clinical Kidney Journal
|
September 29, 2016
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?
Pierre Delanaye, Natalie Ebert, Toralf Melsom, et al.
Clinical Kidney Journal
|
September 29, 2016
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?
Pierre Delanaye, Toralf Melsom, Natalie Ebert, et al.
Journal of the American Society of Nephrology : JASN
|
March 9, 2022
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies <i>in vivo</i> in Severe Kidney Disease: An Open-Label Phase 2a Study
Fredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler, et al.
Kidney Medicine
|
January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
Obbo W Bredewold, Joe Chan, My Svensson, et al.
Frontiers in Transplantation
|
June 29, 2026
An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function
Edwin O W Bredewold, Rudmer J Postma, Joe Chan, et al.
Nature Aging
|
June 10, 2025
Recurrent somatic mutation and progerin expression in early vascular aging of chronic kidney disease
Gwladys Revêchon, Anna Witasp, Nikenza Viceconte, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelines
Anna Åkesson, Carl Öberg, Linnea Malmgren, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Biomedicines
|
April 23, 2022
Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients
Ping-Hsun Wu, Rie Io Glerup, My Hanna Sofia Svensson, et al.
Clinical Transplantation
|
August 16, 2014
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Dag Olav Dahle, Trond Jenssen, Hallvard Holdaas, et al.
Clinical Kidney Journal
|
July 2, 2025
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients
Maria Tydén, Magnus E Westerlund, Kevin Duarte, et al.
Clinical Kidney Journal
|
September 29, 2016
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?
Pierre Delanaye, Natalie Ebert, Toralf Melsom, et al.
Clinical Kidney Journal
|
September 29, 2016
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?
Pierre Delanaye, Toralf Melsom, Natalie Ebert, et al.
Journal of the American Society of Nephrology : JASN
|
March 9, 2022
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies <i>in vivo</i> in Severe Kidney Disease: An Open-Label Phase 2a Study
Fredrik Uhlin, Wladimir Szpirt, Andreas Kronbichler, et al.
Kidney Medicine
|
January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
Obbo W Bredewold, Joe Chan, My Svensson, et al.
Frontiers in Transplantation
|
June 29, 2026
An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function
Edwin O W Bredewold, Rudmer J Postma, Joe Chan, et al.
Nature Aging
|
June 10, 2025
Recurrent somatic mutation and progerin expression in early vascular aging of chronic kidney disease
Gwladys Revêchon, Anna Witasp, Nikenza Viceconte, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelines
Anna Åkesson, Carl Öberg, Linnea Malmgren, et al.
Page
of 3